FDA Clears UriSponge®: A Streamlined, Cost-Effective Solution for Urine Specimen Collection and Transport
Read MoreWASPLAB® AND PHENOMATRIX® AI ARE MAKING WAVES IN CANADA
Read MoreCopan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities
Read MoreCopan Unveils Website Redesign
Read MoreCopan Diagnostics Announces Leadership Change
Read MoreCOPAN Diagnostics Hits the 5 Million Mark on COVID-19 Sample Collection Transport Media Shipped From New Carlsbad Facility
October 22, 2020
COPAN Streamlines Production to Yield Maximum Output of Viral Transport Kits for Collection of Upper Respiratory Samples, Including COVID-19
February 28, 2020
Norman Sharples Receives Achievement Sculpture for 25 Years as CEO of COPAN Diagnostics, Inc.
January 7, 2020
COPAN Continues to Make Great Strides in Advancing Artificial Intelligence (A.I.) and Digital Plate Reading for Microbiology
October 22, 2019
COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIX® for Detection of Group A Streptococcus Using CHROMagar’s COLOREX™ Media
June 14, 2019